Tackling underlying respiratory conditions for this pandemic and next

During the COVID-19 pandemic, one of the many phrases that has become…


Infex partners with Alderley Analytical to provide PK and ADA analysis for RESP-X program

Alderley Park, Cheshire Infex Therapeutics has today announced a deal with…


Infex appoints Lonza to manufacture new lung infection drug

Alderley Park, Cheshire Infex Therapeutics has awarded a £1m contract to Lonza…


Deals agreed as Infex’s resistance bypass drug program heads for clinic

Alderley Park, Cheshire Infex Therapeutics has appointed Pharmaron to help…


Infex focuses on pandemic preparedness with Covid patent

Infex Therapeutics has filed for a UK patent for a novel therapy designed to…